Loading...

TriSalus Life Sciences, Inc.

TLSINASDAQ
Healthcare
Medical - Devices
$4.93
$-0.12(-2.38%)

TriSalus Life Sciences, Inc. (TLSI) Stock Overview

Explore TriSalus Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 68.8/100

Key Financials

Market Cap187.2M
P/E Ratio-5.13
EPS (TTM)$-1.15
ROE1.27%
Fundamental Analysis

AI Price Forecasts

1 Week$5.43
1 Month$4.11
3 Months$3.99
1 Year Target$4.34

TLSI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TriSalus Life Sciences, Inc. (TLSI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.13 and a market capitalization of 187.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.91%
5-Day Change
8.40%
1-Month Change
19.10%
3-Month Change
7.56%
6-Month Change
30.90%
Year-to-Date (YTD) Change
11.45%
1-Year Change
-42.78%
3-Year Change
-43.48%
5-Year Change
-47.24%
All-Time (Max) Change
-47.24%

Contact Information

888 321 5212
6272 West 91st Avenue, Westminster, CO, 80031

Company Facts

110 Employees
IPO DateFeb 8, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;